Related Experiment Video
Updated: Jun 21, 2026
04:03
Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
Published on: September 27, 2024
Acute exacerbation of chronic bronchitis. Guidelines for antibiotic selection
1Emory University School of Medicine, Atlanta, GA 30308, USA.
Postgraduate Medicine
|August 12, 2009
Summary
Bacterial infections, often following viral causes, frequently trigger acute exacerbations of chronic bronchitis (AECB). Optimal antibiotic selection for AECB requires careful patient and exacerbation assessment.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Acute exacerbations of chronic bronchitis (AECB) are commonly initiated by viral infections.
- Impaired mucociliary clearance in chronic bronchitis increases susceptibility to secondary bacterial infections.
- Key bacterial pathogens include Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis, responsible for approximately 50% of AECB cases.
Purpose of the Study:
- To review the common causes and pathogens of acute exacerbations of chronic bronchitis.
- To discuss the principles of antibiotic selection for bacterial AECB.
Main Methods:
- Literature review of bacterial causes of AECB.
- Analysis of common bacterial pathogens implicated in AECB.
- Discussion of antibiotic stewardship principles for AECB.
Main Results:
- Viral infections are a primary trigger for AECB.
- Specific bacteria like H. influenzae, S. pneumoniae, and M. catarrhalis are frequent culprits.
- Antibiotic treatment strategies should be individualized.
Conclusions:
- Effective management of bacterial AECB hinges on appropriate antibiotic selection.
- Stratification based on exacerbation characteristics, patient factors, and antibiotic profiles is recommended.
- Tailored antibiotic therapy optimizes treatment outcomes for AECB.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.